3 Reasons Anavex Stock Could Rise

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 27 June, 2016 by The TZ Newswire Staff

3 Reasons Anavex Stock Could Rise

Cheap Healthcare Money Theme

Image source: Getty Images.

Clinical-stage biotech Anavex Life Sciences (NASDAQ: AVXL) stock has been in a bit of a slump since uplisting from the Wild West of the Pink Sheets to the Nasdaq exchange last October.

See also
- Next Article Trump starts tracking and targeting fans with online ad software
- Previous Article Why AMD Stock Has Exploded 70% Higher in 2016
Editorial Calender

June 2016

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30

« May Jul »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 27 June, 2016 by The TZ Newswire Staff

3 Reasons Anavex Stock Could Rise

See also

Editorial Calender

Recent Tags